what is the difference between berberine and glp 1 a GLP-1 Receptor Agonist? UK Medical Guide – Bolt Pharmacy Berberine and GLP-1: A Natural

Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, and Alba LM

Preclinical and clinical data suggest that FXR and PPAR dual modulators can improve insulin sensitivity, reduce hepatic steatosis, and attenuate fibrosis, which may complement the actions of GLP-1/GIP/GCG receptors agonists

The most commonly reported adverse effects are gastrointestinal in nature and include: Nausea (particularly during dose escalation) Vomiting Diarrhoea Constipation Decreased appetite These effects are generally dose-dependent and tend to be most pronounced during the initial weeks of treatment when the dose is being gradually increased

These secondary endpoints are particularly valuable for researchers studying the broader metabolic impact of triple receptor agonism, as they reflect changes that extend well beyond what the scale measures